An Autonomous National Institute, Government of India, Department of Biotechnology, Ministry of Science & Technology
Home - RGCB | Regional Facility For Molecular Diagnostics
RGCB - Regional Facility For Molecular Diagnostics
Introduction | About | Testing Services

Molecular diagnostics uses molecular signatures for disease identification, monitoring treatment effectiveness and even predicting a patientís response to a new treatment. Although adoption of this technology in the clinical laboratory setting has been slower than anticipated, novel tools continue to create vastly superior alternatives to the established methods. Apart from diagnosis of disease, molecular tests will soon gain more significance as medicine gradually shifts toward targeted or personalized treatment methods. As drug-producing companies realize the gain and value addition in integrating

drug development with companion diagnostics, the field will undergo rapid development. Such companion diagnostics will not only accelerate the discovery and validation of new drugs but also will also decrease the attrition rate. Moreover stratification of the population based on predictive biomarkers will provide a platform for pharmacogenomics, leading to increased efficacy and safety of drugs developed for target populations.